Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Cytidine Deaminase After HCV Therapy
J Viral Hepat; ePub 2016 Mar 4; Cuéllar, et al
The higher expression levels found for activation-induced cytidine deaminase, together with other genes, indicates that these B lymphomagenesis-related genes are upregulated following HCV therapy and this is more marked when HCV can be detected in peripheral blood mononuclear cells (PBMCs). This according to a study of 83 patients with HCV who achieved a sustained virological response (27 with detectable HCV RNA and 56 without), 28 patients with chronic HCV, and 32 healthy controls. Researchers found:
• Patients with chronic HCV and those who achieved an SVR showed a statistically significant higher expression of activation-induced cytidine deaminase, B-aggressive lymphoma, and cyclin D1 vs healthy controls.
• Patients with activation-induced cytidine deaminase, an SVR, and occult infection had a statistically significant higher expression level than patients with an SVR but without occult infection.
Citation: Cuéllar MCR, García-Lozano JR, Sánchez B, et al. Lymphomagenesis-related gene expression in B cells from sustained virological responders with occult hepatitis C virus infection. [Published online ahead of print March 4, 2016]. J Viral Hepat. doi:10.1111/jvh.12526.
This Week's Must Reads
Must Reads in Hepatitis
Glecaprevir/Pibrentasvir Efficacy & Safety Assessed, J Hepatol; ePub 2018 Nov 23; D’Ambrosio, et al
HCV Infection Among Children & Young Persons, J Hepatol; ePub 2018 Nov 26; Modin, et al
HCV Patients with Limited Access to Antiviral Therapy, Dig Liver Dis; ePub 2018 Nov 29; Lens, et al
Progression in the Elimination of HCV Infection, PLoS One; ePub 2018 Dec 4; Juanbeltz, et al
Increased HCV Screening in Veteran Populations, Jt Comm J Qual Patient Saf; ePub 2018 Sep 25; Wray, et al